 |
|
Integrating Primary Medical Care With Addiction Treatment
A Randomized Controlled Trial
Constance Weisner, DrPH;
Jennifer Mertens, MA;
Sujaya Parthasarathy, PhD;
Charles Moore, MD, MBA;
Yun Lu, MPH
JAMA. 2001;286:1715-1723.
Context The prevalence of medical disorders is high among substance abuse patients, yet medical services are seldom provided in coordination with substance abuse treatment.
Objective To examine differences in treatment outcomes and costs between integrated and independent models of medical and substance abuse care as well as the effect of integrated care in a subgroup of patients with substance abuse–related medical conditions (SAMCs).
Design Randomized controlled trial conducted between April 1997 and December 1998.
Setting and Patients Adult men and women (n = 592) who were admitted to a large health maintenance organization chemical dependency program in Sacramento, Calif.
Interventions Patients were randomly assigned to receive treatment through an integrated model, in which primary health care was included within the addiction treatment program (n = 285), or an independent treatment-as-usual model, in which primary care and substance abuse treatment were provided separately (n = 307). Both programs were group based and lasted 8 weeks, with 10 months of aftercare available.
Main Outcome Measures Abstinence outcomes, treatment utilization, and costs 6 months after randomization.
Results Both groups showed improvement on all drug and alcohol measures. Overall, there were no differences in total abstinence rates between the integrated care and independent care groups (68% vs 63%, P = .18). For patients without SAMCs, there were also no differences in abstinence rates (integrated care, 66% vs independent care, 73%; P = .23) and there was a slight but nonsignificant trend of higher costs for the integrated care group ($367.96 vs $324.09, P = .19). However, patients with SAMCs (n = 341) were more likely to be abstinent in the integrated care group than the independent care group (69% vs 55%, P = .006; odds ratio [OR], 1.90; 95% confidence interval [CI], 1.22-2.97). This was true for both those with medical (OR, 3.38; 95% CI, 1.68-6.80) and psychiatric (OR, 2.10; 95% CI, 1.04-4.25) SAMCs. Patients with SAMCs had a slight but nonsignificant trend of higher costs in the integrated care group ($470.81 vs $427.95, P = .14). The incremental cost-effectiveness ratio per additional abstinent patient with an SAMC in the integrated care group was $1581.
Conclusions Individuals with SAMCs benefit from integrated medical and substance abuse treatment, and such an approach can be cost-effective. These findings are relevant given the high prevalence and cost of medical conditions among substance abuse patients, new developments in medications for addiction, and recent legislation on parity of substance abuse with other medical benefits.
Author Affiliations: Department of Psychiatry, University of California, San Francisco (Dr Weisner); Division of Research, Kaiser Permanente Medical Care Program, Northern California Region, Oakland (Drs Weisner and Parthasarathy, Ms Mertens, and Ms Lu); and Kaiser Permanente Chemical Dependency Recovery Program, Sacramento, Calif (Dr Moore).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLES
Methadone Maintenance in Primary Care: A Randomized Controlled Trial
David A. Fiellin, Patrick G. O'Connor, Marek Chawarski, Juliana P. Pakes, Michael V. Pantalon, and Richard S. Schottenfeld
JAMA. 2001;286(14):1724-1731.
ABSTRACT
| FULL TEXT
Generalist Physicians and Addiction Care: From Turfing to Sharing the Turf
Michael D. Stein and Peter D. Friedmann
JAMA. 2001;286(14):1764-1765.
EXTRACT
| FULL TEXT
October 10, 2001
JAMA. 2001;286(14):1779-1780.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies
Mitchell et al.
Br. J. Psychiatry 2009;194:491-499.
ABSTRACT
| FULL TEXT
Substance Use, Symptom, and Employment Outcomes of Persons With a Workplace Mandate for Chemical Dependency Treatment
Weisner et al.
Psychiatr. Serv. 2009;60:646-654.
ABSTRACT
| FULL TEXT
Psychiatrists for Medically Complex Patients: Bringing Value at the Physical Health and Mental Health/Substance-Use Disorder Interface
Kathol et al.
Psychosomatics 2009;50:93-107.
ABSTRACT
| FULL TEXT
An Intervention for Treating Alcohol Dependence: Relating Elements of Medical Management to Patient Outcomes With Implications for Primary Care
Ernst et al.
Ann Fam Med 2008;6:435-440.
ABSTRACT
| FULL TEXT
Medical Clinic Characteristics and Access to Behavioral Health Services for Persons With HIV
Ohl et al.
Psychiatr. Serv. 2008;59:400-407.
ABSTRACT
| FULL TEXT
Nine-Year Psychiatric Trajectories and Substance Use Outcomes: An Application of the Group-Based Modeling Approach
Chi and Weisner
Eval Rev 2008;32:39-58.
ABSTRACT
Longitudinal Course of Substance Treatment Benefits in Older Male Veteran At-Risk Drinkers
Zanjani et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2008;63:98-106.
ABSTRACT
| FULL TEXT
The Life Course Perspective on Drug Use: A Conceptual Framework for Understanding Drug Use Trajectories
Hser et al.
Eval Rev 2007;31:515-547.
ABSTRACT
Maternal Mental Health, Substance Use, and Domestic Violence in the Year After Delivery and Subsequent Behavior Problems in Children at Age 3 Years.
Whitaker et al.
Arch Gen Psychiatry 2006;63:551-560.
ABSTRACT
| FULL TEXT
Organizational Survival in the Outpatient Substance Abuse Treatment Sector, 1988-2000
Wells et al.
Med Care Res Rev 2005;62:697-719.
ABSTRACT
Relationship Between Use of Psychiatric Services and Five-Year Alcohol and Drug Treatment Outcomes
Ray et al.
Psychiatr. Serv. 2005;56:164-171.
ABSTRACT
| FULL TEXT
What Is Known About the Cost-Effectiveness of Health Services for Returning Prisoners?
Howell et al.
J Correct Health Care 2004;10:399-436.
ABSTRACT
Design and Sample Characteristics of the PRISM-E Multisite Randomized Trial to Improve Behavioral Health Care for the Elderly
Levkoff et al.
J Aging Health 2004;16:3-27.
ABSTRACT
Effectiveness and Cost of Olanzapine and Haloperidol in the Treatment of Schizophrenia: A Randomized Controlled Trial
Rosenheck et al.
JAMA 2003;290:2693-2702.
ABSTRACT
| FULL TEXT
Medical and Psychiatric Conditions of Alcohol and Drug Treatment Patients in an HMO: Comparison With Matched Controls
Mertens et al.
Arch Intern Med 2003;163:2511-2517.
ABSTRACT
| FULL TEXT
Cost-effectiveness of Supported Housing for Homeless Persons With Mental Illness
Rosenheck et al.
Arch Gen Psychiatry 2003;60:940-951.
ABSTRACT
| FULL TEXT
Evidence-Based Treatments for Substance Use Disorders
Gold and Brady
Focus 2003;1:115-122.
ABSTRACT
| FULL TEXT
OTHER ARTICLES NOTED (Nov 01 to 18 Oct 02)
Evid. Based Nurs. 2003;6:e1-1.
FULL TEXT
Integrated Delivery Networks: A Detour On The Road To Integrated Health Care?
Burns and Pauly
Health Aff (Millwood) 2002;21:128-143.
ABSTRACT
| FULL TEXT
Other Articles Noted
Evid. Based Ment. Health 2002;5:40-40.
FULL TEXT
Integrating Primary Care and Addiction Care
JWatch Psychiatry 2001;2001:10-10.
FULL TEXT
A 28-Year-Old Man Addicted to Cocaine
Hyman
JAMA 2001;286:2586-2594.
FULL TEXT
Integrating Primary Care and Addiction Care
JWatch General 2001;2001:2-2.
FULL TEXT
Generalist Physicians and Addiction Care: From Turfing to Sharing the Turf
Stein and Friedmann
JAMA 2001;286:1764-1765.
FULL TEXT
|
